211 related articles for article (PubMed ID: 27090386)
1. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
Duan L; Hu X; Jin Y; Liu R; You Q
BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
Wang H; Xie F; Hu Z; Chen L
Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
8. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
[TBL] [Abstract][Full Text] [Related]
9. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
[TBL] [Abstract][Full Text] [Related]
10. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
[TBL] [Abstract][Full Text] [Related]
11. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
Gao Q; Yang S; Kang MQ
Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
[TBL] [Abstract][Full Text] [Related]
12. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
Zhang J; Yu XL; Zheng GF; Zhao F
Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
[TBL] [Abstract][Full Text] [Related]
13. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
14. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
15. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
Wang L; Li X; Li Y; Xue YW
Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
[TBL] [Abstract][Full Text] [Related]
16. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
17. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
